Home / Products / FattaLab®
CES 2026 Innovation Award — Digital Health
FattaLab® - Liver Health Dashboard in the GLP-1 Era
The World’s First Palm-Sized Fatty Liver Intelligent Assessment System. One scan. 30 seconds. Diagnostic-grade liver fat quantification at your fingertips — no ultrasound expertise required.
Product Overview
Fatty Liver Assessment. Wherever Metabolic Care Happens.
FattaLab® is a lightweight, wireless liver fat assessment system pairing a 120g handheld probe with a companion mobile app. It combines AIFF liver fat algorithm, MAP attenuation analysis, and AI-guided 3D acquisition into a single one-button workflow.
Built for the weight-loss clinic that needs repeatable monitoring. The pharmacy adding metabolic screening. The insurer tracking GLP-1 outcomes. The primary care practice that never had access to quantitative liver fat data — until now.
FattaLab®
Lightweight Portable Liver Fat Measurement Device
510 (k) Cleared
The Moment
Why Quantitative Liver Fat Measurement Matters
The market is pivoting from “treat late” to “screen early.” FattaLab® is the point-of-care liver fat assessment for that transition.
The MASH Breakthrough
FDA approved the first targeted NASH drug in 2024, breaking a 40-year treatment gap. GLP-1 therapies for MASH are accelerating diagnosis demand worldwide.
The Diabetes-Liver Nexus
Over 55% of type 2 diabetes patients have comorbid fatty liver disease. The global glucose monitoring market — projected to reach $277B by 2032 — is FattaLab’s natural addressable audience.
The Screening Gap
~80% of early-stage liver disease is asymptomatic. Current methods are either too expensive (MRI-PDFF: $1,000+) or not portable enough. FattaLab® makes routine liver screening as accessible as a blood pressure check.
THE GAP TODAY
Liver Fat Measurement and Monitoring Has Been Stuck in the Radiology Department
Conventional Workflow
Constrained by qualitative assessment and limited monitoring access
Operator-dependent qualitative ultrasound — “mild/moderate/severe” at best
MRI-PDFF at $1,000+ per scan — impractical for serial monitoring
Biopsy as gold standard — invasive, unsuitable for repeat use
No longitudinal liver fat data — you can’t track what you can’t measure
FattaLab® Approach
AI-guided, wireless, and designed for routine liver fat monitoring
AI-guided liver-region recognition — consistent targeting, operator to operator
MAP quantitative dB/m output — same physical principle, handheld form
~30-second scan with automated Smart App analysis — fits any workflow
120g wireless device — deploy anywhere: clinic, pharmacy, screening van, wellness center
Clinical value
Turns liver fat assessment into quantitative dB/m data for metabolic risk discussions.
Workflow value
One-button measurement and automated analysis make repeat monitoring easier to run.
Access value
Brings liver fat testing into clinics, pharmacies, wellness programs, and screening sites.
Coverage value
Connects GLP-1, weight management, insurance, MMC, and nutrition monitoring workflows.
WHY FATTALAB® WINS
Competitive Landscape
Diagnostic-grade accuracy in a pocket-sized device - outperforming MRI-PDFF on cost and portability, body composition scales on clinicalvalidity, and consumer devices on every metric.
| Dimension | FattaLab® | MRI-PDFF | Body Composition Scales | Consumer Devices |
|---|---|---|---|---|
| Accuracy | Diagnostic-grade (MAP vs. MRI-PDFF) | Gold standard | Indirect estimate | Rough proxy |
| Cost | Accessible | $1,000–3,000 / session | Moderate | Low |
| Portability | Pocket-sized (120g) | Hospital-only | Clinic / Home | Home |
| Application | Clinic · Pharmacy · GLP-1 Center · Home | Hospital Radiology | Gym · Clinic | Consumer |
- 30-second measurement - fastest in class
- AI- guided operation - no sonographer needed
- GLP-1 companion - baseline → monitor → maintenance
- FDA 510(k) cleared - K253221
OUR VISION
Health Monitoring 3.0
Just as the electronic blood pressure monitor (1973) made hypertension ahousehold concept and the digital thermometer (1984) normalized homefever tracking - FattaLab® aims to make liver fat measurement a routinevital sign.
ERA 1.0
Weight Management
What We Measured
Body weight alone - a single number that tells you nothing aboutcomposition or organ health.
ERA 2.0
Fat Distribution
What We Measured
BMI, body fat % - better, but still surface-level. Cannotdistinguish visceral from subcutaneous fat.
ERA 3.0- NOW
Visceral Fat Quantification
What We Measured
Liver fat content - the organ that matters most. Diagnostic-gradeaccuracy, pocket-sized, Al-guided.
CLINICAL EVIDENCE
Built on Proven MAP Technology with Ongoing Validation
FattaLab®’s attenuation measurement is validated against Liverscan® MAP in a prospective head-to-head pilot, with ongoing multicenter post-market studies comparing against MRI-PDFF and FibroScan®.
n=68
MASLD Patients
Prospective, head-to-head, same-day comparison with Liverscan® MAP.
r=0.87
Correlation
Pearson vs Liverscan® MAP, P < 0.001
R²=0.76
Goodness of Fit
Pilot comparison agreement
4.2 dB/m
Mean Absolute Error
Vs reference MAP measurement
FDA 510(k) K253221
Cleared February 2026 for professional use.
Technology Architecture
One Platform for Guided Liver Assessment
AIFF Algorithm
Auto Intra-Focus Fusion: AI-powered liver fat detection with liver-region recognition, ROI auto-focus, and subcutaneous-thickness adaptation — consistent measurements across body types.
AI-guided 3D Acquisition
Automatic continuous 3D acquisition captures a volumetric sample rather than a single ultrasound line — 32× the sampling volume of conventional single-beam approaches.
Device + Smart App + AI attenuation analysis
MAP Quantification
Multi-domain attenuation analysis (time-domain + frequency-domain) outputs quantitative dB/m liver fat values. Same physical principle as clinical-grade attenuation — in a 120g probe.
ROI Adaptation
Region of interest automatically adjusts based on subcutaneous thickness, with dedicated control for abdominal obesity populations — a common challenge in MASLD screening.
Clinical Workflow
Liver Fat Measurement Technical Guide
AI-assisted guidance, one-button measurement, and Smart App reporting help FattaLab® fit consultation rooms, screening sites, and metabolic monitoring programs.
Target
AI-assisted positioning with liver-region recognition. App provides real-time visual guidance — no manual landmarking needed.
Measure
120g wireless probe captures 3D attenuation data. One button. Straightforward cases produce results in as little as 30 seconds.
Analyze
AIFF processing: subcutaneous-thickness ROI focus, time/frequency-domain analysis, liver parenchyma recognition. Consistent, automated, operator-independent.
Report
Quantitative dB/m values + trend charts. Built for GLP-1 monitoring, lifestyle intervention tracking, and metabolic health discussions.
Specifications
Technical Details for Evaluation
MAP Fat Quantification
Multi-domain Attenuation Parameter 100–400 dB/m output range
Quantitative liver fat attenuation values for fatty liver screening, metabolic monitoring,and serial comparison
AIFF Algorithm
Human liver fat detection with liver-region recognition and ROI auto-focus
Focuses assessment on liver parenchyma, reduces non-liver interference, supports operator-independent analysis
AI-guided Acquisition
One-button measurement, 3D continuous acquisition, automated analysis, Smart App reports
Supports repeatable monitoring for GLP-1, weight management, wellness, insurance, and screening workflows
Wireless Handheld Device
129.5 × 56.5 × 35.5 mm · 120 g · ≥1 h battery (continuous operation)
Deploys across clinics, pharmacies, screening sites, wellness programs — no cart, no dedicated room
SOLUTIONS
Who Uses Our Non-invasive Liver Fat Measurement
From prescription clinics to pharma trials, FattaLab® powers objective liver health monitoring across the care continuum.
GLP-1 Prescription Clinics
Objective liver fat tracking to demonstrate treatment efficacy and justify therapy continuation.
Medical Aesthetics & Weight-Loss Chains
Premium add-on service with high patient willingness-to-pay — differentiates your clinic.
Bariatric Surgery Centers
Pre-op assessment and post-op longitudinal monitoring of liver health outcomes. Pharmacy-Led Health Programs Walk-in screening drives community engagement and Rx adherence at point-of-care.
Pharmacy-Led Health Programs
Walk-in screening drives community engagement and Rx adherence at point-of-care.
Pharma Companion Diagnostics
Enroll, stratify, and monitor patients in MASH/NASH clinical trials with objective endpoints.
Insurance Wellness Programs
Data-driven risk scoring and incentive program validation for population health management.
Liver Health / Nutraceutical Brands
Product efficacy demonstration at point-of-sale — build consumer trust with objective data.
CES® 2026 Innovation Award Honoree
The CES Innovation Awards, presented by the Consumer Technology Association (CTA), recognize outstanding design and engineering in consumer technology products. FattaLab® earned honors in the Digital Health category at CES 2026 in Las Vegas - a testament to its breakthrough fusion of clinical-grade diagnostics with consumer-friendly design.
2026
CES 2026 Digital Health Innovation Award
Recognition for FattaLab®’s portable digital health workflow and quantitative liver fat monitoring approach. Las Vegas, January 2026.
2026
FDA 510(k) K253221
Professional-use regulatory clearance for FattaLab® liver fat assessment. Cleared February 2026.
FAQ
Why does FattaLab® focus on liver fat?
Liver fat is a core metabolic risk signal in MASLD/MASH and increasingly central to GLP-1 therapy monitoring, lifestyle intervention, and cardiometabolic risk management. It’s the organ-level biomarker most screening programs miss.
What does MAP measure?
MAP (Multi-domain Attenuation Parameter) measures ultrasound attenuation in liver tissue — the same physical principle used in clinical hepatology — and outputs a quantitative liver fat-related value in dB/m. Higher values indicate greater fat accumulation.
Who can operate FattaLab®?
FattaLab® is designed for professional and proximity-care workflows. A trained nurse, pharmacist, or health coach can perform scans after brief device training. No sonographer certification required.
Where can FattaLab® be deployed?
Weight-loss clinics, pharmacies, MMC metabolic centers, corporate wellness programs, insurance health checks, community screening sites, and clinical research programs. Anywhere a 120g wireless probe and a mobile terminal can go.